| scholarly article | Q13442814 |
| P50 | author | Chad Mirkin | Q194539 |
| Steven M. Wolinsky | Q45517979 | ||
| Bette Korber | Q30505218 | ||
| P2093 | author name string | John P Phair | |
| Eun-Young Kim | |||
| Samuel Wu | |||
| Kendall Krebs | |||
| Kevin Kunstman | |||
| Derek Bogdan | |||
| Jennifer Stanton | |||
| P2860 | cites work | Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions | Q40762525 |
| Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings | Q40769676 | ||
| Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings | Q42536793 | ||
| Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease | Q44479082 | ||
| Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States | Q45187954 | ||
| Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement | Q45743381 | ||
| Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection | Q45747370 | ||
| Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants | Q45751414 | ||
| Enzymatic amplification of the human immunodeficiency virus in peripheral blood mononuclear cells from pediatric patients | Q45843752 | ||
| Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium | Q46065436 | ||
| Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. | Q51578688 | ||
| Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy | Q57075703 | ||
| QUASI analysis of the HIV-1 envelope sequences in the Los Alamos National Laboratory HIV sequence database: pattern and distribution of positive selection sites and their frequencies over yearsThis paper is one of a selection of papers in this Specia | Q59191806 | ||
| HIV-1 p24 May Persist During Long-Term Highly Active Antiretroviral Therapy, Increases Little During Short Treatment Breaks, and Its Rebound After Treatment Stop Correlates With CD4+ T Cell Loss | Q59316498 | ||
| Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA | Q59316514 | ||
| Performance of Five Different Assays for the Quantification of Viral Load in Persons Infected With Various Subtypes of HIV-1 | Q59316522 | ||
| Scanometric DNA Array Detection with Nanoparticle Probes | Q60361947 | ||
| Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays | Q69362204 | ||
| U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen | Q71008023 | ||
| Immunopathogenesis of HIV infection | Q71752121 | ||
| Detection of protein analytes via nanoparticle-based bio bar code technology | Q82822372 | ||
| Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay | Q24535105 | ||
| A modular microfluidic architecture for integrated biochemical analysis | Q30475984 | ||
| Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines | Q33780524 | ||
| Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy | Q33816010 | ||
| Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting | Q33856274 | ||
| Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. | Q33963347 | ||
| One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG | Q33972312 | ||
| Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. | Q34076859 | ||
| Diversity considerations in HIV-1 vaccine selection | Q34136023 | ||
| The stoichiometry of Gag protein in HIV-1. | Q34328141 | ||
| RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes | Q34359148 | ||
| Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates | Q34541703 | ||
| A real-time PCR-based method for determining the surface coverage of thiol-capped oligonucleotides bound onto gold nanoparticles | Q34547588 | ||
| Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. | Q36650046 | ||
| Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins | Q38349918 | ||
| Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation | Q38891588 | ||
| Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals | Q39395948 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 293-303 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Nanomedicine | Q15817508 |
| P1476 | title | Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method | |
| P478 | volume | 3 |
| Q30473238 | Advances in developing HIV-1 viral load assays for resource-limited settings |
| Q35755590 | Advancing the speed, sensitivity and accuracy of biomolecular detection using multi-length-scale engineering |
| Q51866785 | Applications of gold nanoparticles in the detection and identification of infectious diseases and biothreats. |
| Q52647635 | Applications of gold nanoparticles in virus detection. |
| Q64083798 | Bio-barcode detection technology and its research applications: A review |
| Q92075025 | Biomedical applications of nanoflares: Targeted intracellular fluorescence probes |
| Q38121489 | Biosensor technology: recent advances in threat agent detection and medicine |
| Q37980242 | DNA-assisted protein detection technologies |
| Q37764940 | Detection of blood-transmissible agents: can screening be miniaturized? |
| Q60302947 | Detection of purified ESAT-6 (Rv3875) by magnetic bead-coupled gold nanoparticle-based immuno-PCR assay |
| Q35678689 | Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda |
| Q30656033 | Direct Reading of Bona Fide Barcode Assays for Diagnostics with Smartphone Apps |
| Q34486159 | Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques. |
| Q37140373 | Increased Sensitivity of HIV-1 p24 ELISA Using a Photochemical Signal Amplification System |
| Q94600878 | Materials Science in the time of Coronavirus |
| Q37538776 | NanoART, neuroAIDS and CNS drug delivery |
| Q38374911 | Nanomaterial-based biosensors using dual transducing elements for solution phase detection |
| Q33759991 | Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence |
| Q30386281 | Nanoparticle detection of respiratory infection. |
| Q90385471 | Nanoscale dynamic chemical, biological sensor material designs for control monitoring and early detection of advanced diseases |
| Q37577230 | Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences |
| Q35171307 | Preclinical detection of porcine circovirus type 2 infection using an ultrasensitive nanoparticle DNA probe-based PCR assay |
| Q38940938 | Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections. |
| Q36394635 | Two types of nanoparticle-based bio-barcode amplification assays to detect HIV-1 p24 antigen |
| Q24289293 | Virus detection and quantification using electrical parameters |
Search more.